This invention provides new antifungal compounds of Formula I or II: or Formula II: whereinn is 3 to 10;R is hydrogen, C1-C4 alkyl or a pharmaceutically acceptable salt cation selected from the group consisting of sodium, potassium, calcium, lithium, magnesium, ammonium, and tetra(C1-C4)alkyl ammonium; and R1 is hydrogen or methyl and in formula I, R2 is hydrogen or methyl: and their production by fermentation and use as antifungal agents.
展开▼
机译：本发明提供了式I或II的新的抗真菌化合物： <图像文件=“ IMGA0001.GIF” he =“ 68” id =“ ia01” imgContent =“ chem” imgFormat =“ GIF” wi =“ 92” /> 或公式II： <图像文件=“ IMGA0002.GIF” he =“ 66” id =“ ia02” imgContent =“ chem” imgFormat =“ GIF” wi =“ 85” /> 其中n为3至10;R是氢，C 1 -C 4 烷基或选自钠，钾，钙，锂，镁，铵和四的药学上可接受的盐阳离子（C 1 -C 4 ）烷基铵;和R 1 是氢或甲基，在式I中，R 2 是氢或甲基：及其通过发酵生产并用作抗真菌剂。
展开▼
